← Back to headlines
Eris Lifesciences and Natco Pharma Sign Pact on Semaglutide
Indian pharmaceutical companies Eris Lifesciences and Natco Pharma have entered into an agreement concerning the drug Semaglutide.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
